BOI

FR0000061129

Pharmaceuticals

Real-time Euronext Paris Other stock markets 05:42:53 2024-04-26 am EDT			5-day change	1st Jan Change
34.65 ^EUR	+1.02%		+2.51%	-13.85%

Feb. 02	Boiron: nearly 600,000 shares tendered to the OPAS	CF
Jan. 11	Boiron: OPAS open from January 11 to 31	CF

Boiron : Projected timetable of the next publications and events 2021

October 15, 2020 at 04:05 am EDT

The projected timetable of the next publications and events for the year 2021 is the following one:

Publications	Date of publication (after market closing)	Information meetings
Annual sales of 2020 Quiet period from Wednesday, January 6, 2021	Thursday, January 21, 2021
Annual results of 2020 Quiet period from Tuesday, February 9, 2021	Wednesday, March 10, 2021	Thursday, March 11, 2021
1^st quarter sales of 2021 Quiet period from Wednesday, April 7, 2021	Thursday, April 22, 2021
Shareholders' Meeting 2021	Thursday, May 27, 2021
Half-year sales of 2021 Quiet period from Monday, July 5, 2021	Tuesday, July 20, 2021
Half-year results of 2021 Quiet period from Monday, August 9, 2021	Wednesday, September 8, 2021	Thursday, September 9, 2021 Webcast
3^rd quarter sales of 2021 Quiet period from Wednesday, October 6, 2021	Thursday, October 21, 2021

Quiet period: during the period prior to the publications, BOIRON limits its communication with the financial community.

Our next update:

October 22, 2020, at market close, publication of quarterly sales and financial information as of September 30, 2020.

Person responsible for financial information: Valérie Lorentz-Poinsot.

Contact for financial information: Fabrice Rey.

Investor relations: +33 (0) 4.37.41.84.01 - e-mail : boironfinances@boiron.fr

ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA

The group's financial information and the glossary are online at: www.boironfinance.com

This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: mmhxYsiXaW3Iy2xpY8htm2ZnnJuSxZacZmqWlJNxmMrGnJqSx25qmZzIZm9mmmxv
- Check this key: https://www.security-master-key.com.

Regulated information:
Inside Information:
- other releases

Full and original press release in PDF: https://www.actusnews.com/news/65579-boi-151020-calendrier-des-publications-2020-2021-gb.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

© 2020 ActusNews

Latest news about BOIRON

Boiron: nearly 600,000 shares tendered to the OPAS	Feb. 02	CF
Boiron: OPAS open from January 11 to 31	Jan. 11	CF
Boiron: Orfim crosses the 5% threshold	23-10-13	CF
Boiron: agreement to sell majority stake signed	23-10-05	CF
Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-10	CI
Boiron: share price up, analyst raises target	23-09-07	CF
Oddo BHF Raises Boiron PT, Maintains Outperform Rating	23-09-07	MT
BOIRON : Oddo BHF raises its target price on the stock	23-09-07	CF
Boiron: 23% rise in half-year net income	23-09-07	CF
Boiron: sales down by almost 7% in 1st half-year	23-07-19	CF
Boiron: family shareholders to launch takeover bid	23-07-04	CF
Boiron: listing suspended prior to announcement	23-07-04	CF
Boiron SAÂ Board intends to launch an Equity Buyback onÂ July 4, 2023.	23-07-04	CI
Boiron: in the green after its quarterly sales figures	23-04-28	CF
Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Boiron: 56.4% increase in net income by 2022	23-03-21	CF
Boiron SA Recommends Dividend, Payable on June 3, 2023	23-03-20	CI
CAC40: day in green, week in red, close to 7000pts	23-01-20	CF
CAC40: back above 7,000, despite sharp rise in interest rates	23-01-20	CF
CAC40: flirts with 7,000, gap with US indices widens	23-01-20	CF
CAC40: back on the right foot after yesterday's plunge	23-01-20	CF
Boiron: 17% growth in annual sales	23-01-20	CF
Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-15	CI
Global markets live: Novartis, Tesla, Disney, Sony, Walmart...	22-06-29
Galenica's Verfora To Take Over Distribution Of Boiron Products In Switzerland	22-06-29	MT

Chart BOIRON

Duration

Period

More charts

Company Profile

Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).

Sector

Pharmaceuticals

Calendar

2024-05-22 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for BOIRON

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

34.3 EUR

Average target price

39.6 EUR

Spread / Average Target

+15.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
BOIRON	-13.85%	638M
DONG-E-E-JIAO CO.,LTD.	+37.37%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.69%	4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.12%	3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.47%	2.61B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.06%	1.81B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.84%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.60%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.03%	1.55B

Alternative Medicine

BOIRON

Equities

BOI

FR0000061129

Pharmaceuticals

Boiron : Projected timetable of the next publications and events 2021

Latest news about BOIRON

Chart BOIRON

Company Profile

Income Statement Evolution

Ratings for BOIRON

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Alternative Medicine